What is ALIQOPA?
ALIQOPA is a prescription medicine used to treat adults with follicular lymphoma (FL) when the disease has come back after treatment with at least two prior medicines.
What is the most important information I should know about ALIQOPA?
ALIQOPA can cause serious side effects. These serious side effects include:
- Infections. ALIQOPA can cause serious infections that may lead to death. The most common serious infection was pneumonia. Tell your healthcare provider right away if you have a fever or any signs of an infection during treatment with ALIQOPA.
- High blood sugar (hyperglycemia). High blood sugar is common following ALIQOPA infusion and can sometimes be serious. Tell your healthcare provider if you develop any symptoms of hyperglycemia during treatment with ALIQOPA. Symptoms of hyperglycemia may include: being very hungry, headache, being very thirsty, frequent urination
- High blood pressure (hypertension). High blood pressure is common following ALIQOPA infusion and can sometimes be serious.
- Lung or breathing problems. Your healthcare provider may do tests to check your lungs if you have breathing problems during treatment with ALIQOPA. Tell your healthcare provider right away if you develop new or worsening cough, shortness of breath, or difficulty breathing.
- Low white blood cell count (neutropenia). Neutropenia is common with ALIQOPA treatment and can sometimes be serious. Your healthcare provider will check your blood counts regularly during treatment with ALIQOPA. Tell your healthcare provider right away if you have a fever or any signs of infection during treatment with ALIQOPA.
- Severe skin reactions. Skin peeling, rash, and itching are common with ALIQOPA and can sometimes be serious. Tell your healthcare provider if you develop skin peeling, itching, or rash during treatment with ALIQOPA. Your healthcare provider may withhold treatment, decrease your dose, or permanently stop treatment if you develop severe skin reactions during treatment with ALIQOPA.
- The most common side effects of ALIQOPA include:
- low white blood cell count (leukopenia)
- decreased strength and tiredness
- lower respiratory tract infection
- nausea
- diarrhea
- low platelets in your blood (thrombocytopenia)
These are not all of the possible side effects of ALIQOPA. Call your doctor for medical advice about side effects.
How will I receive ALIQOPA?
- ALIQOPA will be given to you by a healthcare provider as an intravenous (IV) injection into your vein over 1 hour.
- You will receive your ALIQOPA treatment 1 time every week for 3 weeks and then stop for 1 week. This is 1 cycle of treatment. ALIQOPA is usually given on Day 1, Day 8, and Day 15 of a 28-day treatment cycle.
- Your healthcare provider will decide how many treatment cycles you need.
- Your healthcare provider may withhold treatment, decrease your dose, temporarily stop, or permanently stop treatment with ALIQOPA if you have certain side effects.
Insert text here
Important Safety Information
- Avoid taking St. John’s Wort during treatment with ALIQOPA.
- Avoid drinking grapefruit juice during treatment with ALIQOPA.
Ask your healthcare provider if you do not know.
What should I tell my healthcare provider before taking ALIQOPA?
Before receiving ALIQOPA, tell your healthcare provider about all of your medical conditions, including if you:
- have an infection
- have lung or breathing problems
- have high blood pressure (hypertension)
- have diabetes or high blood sugar (hyperglycemia)
- are pregnant or plan to become pregnant. ALIQOPA can harm your unborn baby.
- Your healthcare provider will perform a pregnancy test before starting treatment with ALIQOPA.
- Females who are able to become pregnant should use effective birth control (contraception) during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA. Talk to your healthcare provider about birth control methods that may be right for you. Tell your healthcare provider right away if you become pregnant or think you are pregnant during treatment with ALIQOPA.
- Males with female partners who are able to become pregnant should use effective birth control (contraception) during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA.
- are breastfeeding or plan to breastfeed. It is not known if ALIQOPA passes into your breast milk. Do not breastfeed during treatment with ALIQOPA and for at least 1 month after the last dose of ALIQOPA. Talk to your healthcare provider about the best way to feed your child during treatment with ALIQOPA.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Certain other medicines may affect how ALIQOPA works.
It is not known if ALIQOPA is safe and effective in children
General information about ALIQOPA
Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. You can ask your healthcare provider or pharmacist for information about ALIQOPA that is written for health professionals.
What are the ingredients in ALIQOPA?
Active ingredient: Copanlisib
Other ingredient: Citric acid anhydrous, mannitol, sodium hydroxide